apoB
Selected indexed studies
- The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia. (Genes (Basel), 2021) [PMID:33418990]
- Biosynthesis and Metabolism of ApoB-Containing Lipoproteins. (Annu Rev Nutr, 2024) [PMID:38635875]
- ApoB. (Circ Res, 2019) [PMID:31070997]
_Worker-drafted node — pending editorial review._
Connections
apoB is a risk factor for
Sources
- The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia. (2021) pubmed
- Biosynthesis and Metabolism of ApoB-Containing Lipoproteins. (2024) pubmed
- ApoB. (2019) pubmed
- ApoB in clinical care: Pro and Con. (2019) pubmed
- High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 2: a review basis for updating guidelines. (2025) pubmed
- Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice. (2024) pubmed
- ApoB versus non-HDL-C: what to do when they disagree. (2009) pubmed
- High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines. (2025) pubmed
- Novel APOB mutation in familial hypobetalipoproteinemia. (2022) pubmed
- Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial. (2024) pubmed